Search

Your search keyword '"Reduzzi, Carolina"' showing total 311 results

Search Constraints

Start Over You searched for: Author "Reduzzi, Carolina" Remove constraint Author: "Reduzzi, Carolina"
311 results on '"Reduzzi, Carolina"'

Search Results

4. Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study

5. Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors

8. Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis

10. Analysis of single circulating tumor cells (CTCs) to infer phenotype and genome changes in response to therapeutic pressures in biliary tract cancer

15. Racial differences in genomic profiles and targeted treatment use in ER+ HER2- metastatic breast cancer.

16. The Role of Liquid Biopsy as a Catalyst for Sustained Progress in Precision Oncology – Perspective of The Young Committee of The International Society of Liquid Biopsy

21. Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker Analysis

24. ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer

25. Surfactant-assisted one-pot sample preparation for label-free single-cell proteomics

28. Development of a Protocol for Single-Cell Analysis of Circulating Tumor Cells in Patients with Solid Tumors

29. Supplementary Video S20 from Dynamic Glycoprotein Hyposialylation Promotes Chemotherapy Evasion and Metastatic Seeding of Quiescent Circulating Tumor Cell Clusters in Breast Cancer

30. Supplementary Excel S3 from Dynamic Glycoprotein Hyposialylation Promotes Chemotherapy Evasion and Metastatic Seeding of Quiescent Circulating Tumor Cell Clusters in Breast Cancer

31. Data from Dynamic Glycoprotein Hyposialylation Promotes Chemotherapy Evasion and Metastatic Seeding of Quiescent Circulating Tumor Cell Clusters in Breast Cancer

32. Supplementary Tables S1-S2 from Dynamic Glycoprotein Hyposialylation Promotes Chemotherapy Evasion and Metastatic Seeding of Quiescent Circulating Tumor Cell Clusters in Breast Cancer

33. Supplementary Figures S1-S17 from Dynamic Glycoprotein Hyposialylation Promotes Chemotherapy Evasion and Metastatic Seeding of Quiescent Circulating Tumor Cell Clusters in Breast Cancer

34. Data from Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer

35. Supplementary Tables 1 from Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer

36. Supplemental Figure 3 from Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer

37. Supplemental Figure 1 from Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer

38. Supplementary Data 1 from Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer

39. Supplemental Figure 2 from Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer

40. Dynamic Glycoprotein Hyposialylation Promotes Chemotherapy Evasion and Metastatic Seeding of Quiescent Circulating Tumor Cell Clusters in Breast Cancer

41. Circulating Tumor Cells Prediction in Hormone Receptor Positive HER2-Negative Advanced Breast Cancer: A Retrospective Analysis of the MONARCH 2 Trial.

42. Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer

43. Computational ranking-assisted identification of Plexin-B2 in homotypic and heterotypic clustering of circulating tumor cells in breast cancer metastasis

45. Abstract 304: Micronuclei in circulating stromal cells correlates with PD-L1 expression and predicts progression in metastatic breast cancer

47. Abstract P6-10-15: Targeting MARCKS in inflammatory breast cancer increased paclitaxel sensitivity

49. Abstract PD10-01: PD10-01 Impact of ESR1 mutations on Selective Estrogen Receptor Degraders and Modulators: an integrated liquid-biopsy and pharmacodynamics approach

50. Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer

Catalog

Books, media, physical & digital resources